等待開盤 09-17 09:30:00 美东时间
-1.170
-2.38%
今日重点评级关注:Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.3美元升至8.45美元;摩根大通:维持Vera Therapeutics"超配"评级,目标价从76美元升至83美元
09-09 15:36
Morgan Stanley analyst Manan Gosalia downgrades Bank OZK (NASDAQ:OZK) from Equal-Weight to Underweight and maintains the price target from $56 to $56.
09-09 01:56
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Wells Fargo analyst Terry McEvoy maintains Bank OZK (NASDAQ:OZK) with a Equal-Weight and raises the price target from $52 to $56.
08-11 01:23
Wall Street has always insisted that investors must choose sides. You can own growth stocks, which supposedly offer exciting capital gains but little current income. You can own dividend stocks, which provide income but are often dismissed as slow, boring businesses unlikely to produce spectacular l...
08-08 04:30
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
今日重点评级关注:HC Wainwright & Co.:维持居里"买入"评级,目标价从17美元升至43美元;花旗:维持Klaviyo"买入"评级,目标价从31美元升至34美元
07-27 14:02
TD Cowen analyst Janet Lee maintains Bank OZK (NASDAQ:OZK) with a Hold and lowers the price target from $53 to $52.
07-25 00:46
Bank OZK (NASDAQ:OZK) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.47 by 1.36 percent. This is a 5.7 percent decrease over earnings of $1.58 per share from the same period last year. The company reported quarterly sales of $430.020 million which miss...
07-22 04:23
今日重点评级关注:Roth Capital:维持Nuvectis Pharma"买入"评级,目标价从20美元升至33美元;摩根士丹利:维持GXO Logistics"超配"评级,目标价从75美元升至78美元
07-07 11:34